| ACALABRUTINIB |
Calquence® |
AstraZeneca Pty Ltd |
Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) |
Mar 2020 |
|
| ADALIMUMAB |
Hyrimoz® |
Sandoz Pty Ltd |
Crohn disease; Ulcerative colitis; Juvenile idiopathic arthritis; Fistulising Crohn
disease; Rheumatoid arthritis; Psoriatic arthritis; Ankylosing spondylitis; Chronic
plaque psoriasis; Hidradenitis suppurativa |
Mar 2020 |
|
| ALIROCUMAB |
Praluent® |
sanofi-aventis Australia Pty Ltd |
Hypercholesterolaemia |
Mar 2020 |
|
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE |
PKU Lophex® |
Nutricia Australia Pty Limited |
Phenylketonuria (PKU) |
Mar 2020 |
|
| AMINO ACID SYNTHETIC FORMULA SUPPLEMENTED WITH LONG CHAIN POLYUNSATURATED FATTY ACIDS
AMINO ACID FORMULA SUPPLEMENTED WITH PREBIOTICS, PROBIOTICS AND LONG CHAIN POLYUNSATURATED
FATTY ACIDS |
Neocate LCP® Neocate Syneo® |
Nutricia Australia Pty Limited |
Cow’s milk allergy, multiple food intolerance and other medical conditions where an
amino acid-based formula is recommended |
Mar 2020 |
|
| APOMORPHINE |
- Apomine® Solution for Infusion
- Apomine® Intermittent
|
Pfizer Australia Pty Ltd |
Parkinson Disease |
Mar 2020 |
|
| ATEZOLIZUMAB |
Tecentriq® |
Roche Products Pty Ltd |
Breast cancer |
Mar 2020 |
|
| ATEZOLIZUMAB |
Tecentriq® |
Roche Products Pty Ltd |
Extensive-stage primary small cell carcinoma of lung |
Mar 2020 |
|
| AVELUMAB |
Bavencio® |
Merck Healthcare Pty Ltd |
Renal cell carcinoma (RCC) |
Mar 2020 |
|
| BENRALIZUMAB |
Fasenra Pen® |
AstraZeneca Pty Ltd |
Eosinophilic asthma |
Mar 2020 |
|
| BEZLOTOXUMAB |
Zinplava® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Prevention of recurrent clostridium difficile infection (CDI) |
Mar 2020 |
|
| BROLUCIZUMAB |
Beovu® |
Novartis Pharmaceuticals Australia Pty Limited |
Subfoveal choroidal neovascularisation |
Mar 2020 |
|
| BUPRENORPHINE AND NALOXONE |
Zubsolv® |
Mundipharma Pty Limited |
Opiate dependence |
Mar 2020 |
|
| CABOZANTINIB |
Cabometyx® |
Ipsen Pty Ltd |
Renal cell carcinoma (RCC) |
Mar 2020 |
|
| DUPILUMAB |
Dupixent® |
sanofi-aventis Australia Pty Ltd |
Atopic dermatitis |
Mar 2020 |
|
| ENTRECTINIB |
Rozlytrek® |
Roche Products Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Mar 2020 |
|
| FLUOCINOLONE ACETONIDE |
Iluvien® |
Specialised Therapeutics Pharma Pty Ltd |
Diabetic macular oedema |
Mar 2020 |
|
| FREMANEZUMAB |
Ajovy® |
Teva Pharma Australia Pty Ltd |
Chronic migraine |
Mar 2020 |
|
| LISDEXAMFETAMINE |
Vyvanse® |
Shire Australia Pty Ltd |
Attention defecit hyperactivity disorder (ADHD) |
Mar 2020 |
|
| MEPOLIZUMAB |
Nucala® |
GlaxoSmithKline Australia Pty Ltd |
Uncontrolled severe eosinophillic asthma |
Mar 2020 |
|
| MESALAZINE |
Pentasa® |
Ferring Pharmaceuticals Pty Limited |
Ulcerative proctitis Ulcerative colitis Crohn disease |
Mar 2020 |
|
| METHYLPHENIDATE |
Ritalin® LA |
Novartis Pharmaceuticals Australia Pty Limited |
Attention defecit hyperactivity disorder (ADHD) |
Mar 2020 |
|
| MILK PROTEIN AND FAT FORMULA WITH VITAMINS AND MINERALS CARBOHYDRATE FREE |
Carbohydrate Free Mix® |
Nutricia Australia Pty Limited |
Ketogenic diet |
Mar 2020 |
|
| NABIXIMOLS |
Sativex® |
Emerge Health Pty Ltd |
Multiple sclerosis (MS) related spasticity |
Mar 2020 |
|
| OLAPARIB |
Lynparza® |
AstraZeneca Pty Ltd |
Ovarian fallopian tube or primary peritoneal cancer |
Mar 2020 |
|
| ONDANSETRON |
Various brands |
Medical Oncology Group of Australia |
Nausea and vomiting associated with cytotoxic chemotherapy |
Mar 2020 |
|
| OZANIMOD |
Zeposia® |
Celgene Pty Limited |
Relapsing-remitting multiple sclerosis (RRMS) |
Mar 2020 |
|
| PEGFILGRASTIM |
Pelgraz |
Accord Healthcare Pty. Ltd. |
Chemotherapy-induced neutropenia |
Mar 2020 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Melanoma |
Mar 2020 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Melanoma |
Mar 2020 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Primary mediastinal B-cell lymphoma (PMBCL) |
Mar 2020 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Melanoma Non-small cell lung cancer (NSCLC) |
Mar 2020 |
|
| PERTUZUMAB |
Perjeta® |
Roche Products Pty Ltd |
Breast cancer |
Mar 2020 |
|
| PLITIDEPSIN |
Aplidin® |
Specialised Therapeutics Pharma Pty Ltd |
Multiple myeloma |
Mar 2020 |
|
| PROTEIN FORMULA WITH CARBOHYDRATE, FAT, VITAMINS, MINERALS AND TRANSFORMING GROWTH
FACTOR BETA-2 |
Modulen IBD® |
Nestle Australia Ltd |
Crohn disease |
Mar 2020 |
|
| RIVAROXABAN |
Xarelto® |
Bayer Australia Ltd |
Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD) |
Mar 2020 |
|
| ROMOSOZUMAB |
Evenity® |
Amgen Australia Pty Limited |
Osteoporosis |
Mar 2020 |
|
| SEMAGLUTIDE |
Ozempic® |
Novo Nordisk Pharmaceuticals Pty. Limited |
Type 2 diabetes mellitus (T2DM) |
Mar 2020 |
|
| STIRIPENTOL |
Diacomit® |
Emerge Health Pty Ltd |
Severe myoclonic epilepsy in infancy (SMEI) |
Mar 2020 |
|
| TOCILIZUMAB |
Actemra® |
Roche Products Pty Ltd |
Severe active juvenile idiopathic arthritis (JIA) |
Mar 2020 |
|
| TOFACITINIB |
Xeljanz® |
Pfizer Australia Pty Ltd |
Chronic plaque psoriasis Psoriatic arthritis Rheumatoid arthritis Ulcerative arthritis |
Mar 2020 |
|
| TRIGLYCERIDES MEDIUM CHAIN AND LONG CHAIN WITH GLUCOSE POLYMER |
Duocal® |
Nutricia Australia Pty Limited |
Proven inborn errors of protein metabolism |
Mar 2020 |
|
| TRIGLYCERIDES MEDIUM CHAIN FORMULA |
Lipistart® |
Vitaflo Australia Pty Limited |
Dietary management of conditions requiring a source of medium chain triglycerides |
Mar 2020 |
|
| TRIGLYCERIDES MEDIUM CHAIN FORMULA |
Peptamen® Junior |
Nestle Australia Ltd |
Dietary management of conditions requiring a source of medium chain triglycerides |
Mar 2020 |
|
| VENETOCLAX |
Venclexta® |
AbbVie Pty Ltd |
Chronic lymphocytic leukaemia (CLL) |
Mar 2020 |
|
| WHEY PROTEIN FORMULA SUPPLEMENTED WITH AMINO ACIDS, LONG CHAIN POLYUNSATURATED FATTY
ACIDS, VITAMINS AND MINERALS, LOW IN PROTEIN, PHOSPHATE, POTASSIUM AND LACTOSE |
Renastart® |
Vitaflo Australia Pty Limited |
Chronic kidney disease (CKD) |
Mar 2020 |
|